Welcome address: Karun Rishi, President, USAIC
Opening comments by Chair and Master of Ceremonies (Emcee): Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

Fireside Chat: Dr. Robert Califf, Commissioner of Food and Drugs, US Food and Drug Administration
Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

Fireside Chat: Joaquin Duato, Chairman & CEO, Johnson & Johnson
Moderator: Kenneth Frazier, Chairman, Health Assurance Initiatives, General Catalyst and former Chairman & CEO, Merck & Co.

Fireside Chat: Dr. Albert Bourla, Chairman and Chief Executive Officer, Pfizer
Moderator: Dr. Stelios Papadopoulos, Chairman, Biogen

Panelists:
Amitabh Kant, G20 Sherpa, G20
Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
Moderator: 
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Panelists:
Badhri Srinivasan, Head, Global Clinical Operations, Novartis
Dr. Cynthia Verst, President, Design & Delivery Innovation for R&D Solutions, IQVIA
Dr. Naresh Trehan, Chairman, Medanta - the Medicity
Dr. Shiv Kumar Sarin, Chancellor, Institute of Liver and Biliary Sciences
Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog
Moderator:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

Panelists:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
Dr. Daniel Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. Fiona Marshall, President, Novartis Institutes for BioMedical Research
Moderator:
Dr. Martin Mackay, Co-Founder, Rallybio

Panelists:
Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health
Dr. Marcus Schindler, Executive Vice President, Research & Early Development and Chief Scientific Officer, Novo Nordisk
Dr. Mathai Mammen, CEO Designate, FogPharma
Dr. Phillip Sharp, Institute Professor, Koch Institute, MIT
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Moderator:
Dr. Susan Hockfield, President Emerita, MIT

Panelists:
Dr. Alice Zhang, Co-Founder & CEO, Verge Genomics
Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals
Dr. Dina Katabi, Professor of Computer Science, Member - CSAIL, Massachusetts Institute of Technology
Dr. Junaid Bajwa, Chief Medical Scientist, Microsoft
Sastry Chilukuri former Co-CEO, Medidata

Moderator:
Dr. Najat Khan, Chief Data Science Officer and Global Head of Janssen R&D Strategy and Operations, Janssen R&D, Johnson & Johnson

Panelists:
Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
Dr. Frank Nestle, Global Head of Research and Chief Scientific Officer, Sanofi
Dr. Kathy Seidl, Vice President, Head of the Oncology Drug Discovery Unit, Takeda
Dr. Katy Rezvani, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research, MD Anderson Cancer Center
Rehan Verjee, Co-Founder & Chief Executive Officer, Stealth start-up
Moderator:
Dr. James Bradner, Physician Scientist, Former President, Novartis Institutes for BioMedical Research

Panelists:
Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
Christopher Viehbacher, President & CEO, Biogen
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Managing Partner, F-Prime Capital
Theresa Tse, Chairwoman of Board Committee, Sino Biopharmaceutical Limited
Moderator:
Dr. Samuel Waksal, Chairman and Chief Executive Officer, Graviton Biosciences

Closing Remarks: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

Panelists:
Dr. Christine Ward, Vice President, Head of Oncology and Cell Therapy, Takeda Pharmaceuticals
Dr. Eric Rubin, Senior Vice President, Therapeutic Area Head Oncology, Early Development, Merck Research Labs
Dr. Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
Dr. Sam Waksal, Chairman and Chief Executive Officer, Equilibre Biopharmaceuticals
Dr. Todd Golub, Director and Founding Core Member, Broad Institute of MIT & Harvard

Moderator:
Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

Fireside Chat: Alex Gorsky, Executive Chairman, Johnson & Johnson
Moderator: Christopher Viehbacher, Founding Partner, Gurnet Point Capital

Panelists:
Dr. Cynthia Verst, President, Design & Delivery Innovation for Research and Development Solutions, IQVIA
Dr. Kush Parmar, Managing Partner, 5AM Ventures
Dr. Naresh Trehan, Chairman, Medanta
Peter Ronco, Head of Global Development, Janssen Research and Development, Johnson & Johnson
Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog

Moderator:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

Panelists:
Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
Dr. Karen Akinsanya, President of Research and Development, Therapeutics, Schrodinger
Dr. Regina Barzilay, Professor of AI and Health, Massachusetts Institute of Technology
Sastry Chilukuri, Co-Chief Executive Officer, Medidata
Dr. Vipin Gopal, Chief Data & Analytics Officer, Eli Lilly

Moderator:
Chris Benko, Co-Founder and Chief Executive Officer, Koneksa Health

Panelists:
Dr. Larry Tabak, Acting Director, National Institutes of Health (NIH)
Dr. John Mascola, Chief Scientific Officer, ModeX Therapeutics
Dr. Julie Gerberding, Chief Executive Officer, Foundation for the NIH (FNIH)
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Moderator:
Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

Panelists:
Christopher Viehbacher, Founding Partner, Gurnet Point Capital
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

Moderator:
Jennifer Fox, Chief Financial Officer, Nuvation Bio

Panelists:
Dr. Alfred Sandrock, Chief Executive Officer, Voyager Therapeutics
Charlene Son Rigby, Chief Executive Officer, RARE-X
Paula Soteropoulos, Chairman of the Board, Ensoma
Dr. Philip Larsen, Global Head of Research, Bayer Pharma
Max Bronstein, Assistant Director for Health Innovation, White House Office of Science & Technology Policy

Moderator:
Dr. Timothy Yu, Associate Professor in Pediatrics, Harvard Medical School

Panelists:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. John Reed, Global Head of Research and Development, Sanofi
Dr. Mathai Mammen, Executive Vice President, Pharmaceuticals, Research and Development, Johnson & Johnson

Moderator: 
Dr. Martin Mackay, Co-Founder, Rallybio

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals, Advisory Board Members and Speakers

Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

Dr. Albert Bourla, Chairman & CEO, Pfizer
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

Dr. Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals, Dr. David Reese, Executive Vice President, Research and Development, Amgen, Dr. John Reed, Global Head of R&D, Sanofi, Dr. Mathai Mammen, Global Head of Janssen R&D, Johnson & Johnson
Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India, Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Limited, Prof. K. Vijay Raghavan, Principal Scientific Advisor, Government of India, Dr. Naresh Trehan, Chairman, Medanta Hospital
Moderator: Sanat Chattopadhyay, President- Merck Manufacturing Division, Merck & Co.

Fireside Chat: Robert Bradway, Chairman & CEO, Amgen
Moderator: Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Fireside Chat: Dr. Francis Collins, Director, National Institutes of Health, Dr. Margaret Hamburg, Former Commissioner, U.S. Food and Drug Administration
Moderator: Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

Panelists: Dr. Bruce Chabner, Director of Clinical Research, Massachusetts General Hospital Cancer Center, Dr. Carrie Brownstein, Chief Medical Officer, Cellectis, Dr. Philip Larsen, Global Head of Research, Bayer AG, Dr. Sam Waksal, Founder, MeiraGTx, Vivek Ramaswamy, Founder & Executive Chairman, Roivant Sciences
Moderator: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital, Dr. Peter Orszag, Chief Executive Officer - Financial Advisory, Lazard Freres, Rajiv Kaul, Portfolio Manager, Fidelity Investments, Dr. Stelios Papadopoulos, Chairman, Biogen
Moderator: Daphne Zohar, Co-Founder and Chief Executive Officer, PureTech Health

Panelists: Craig Kennedy, Senior Vice President, Merck & Co., Dr. Daphne Koller, Founder & CEO, insitro, Dr. Karen Akinsanya, Chief Biomedical Scientist, Schrödinger, Dr. Najat Khan, Chief Data Science Officer, Janssen Research & Development, Dr. Robert Califf, Head of Clinical Policy & Strategy, Verily & Google Health
Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

Panelists: Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals, Dr. Frank Bennett, Chief Scientific Officer, Ionis Pharmaceuticals, Dr. John Orloff, Head of Research & Development, Alexion, Dr. Katherine High, President - Therapeutics, AskBio, Majid Jafar, Co-Founder, Loulou Foundation
Moderator: Dr. Alfred Sandrock, Head of Research and Development, Biogen
 

Opening comments:  Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

Panelists: Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health; Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda; Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India; Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization
Moderator: Muna Bhanji, Senior Vice President,  Merck & Co.

Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co.
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI); Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India; Dr. Naresh Trehan, Chairman, Medanta - the Medicity
Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.

Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic; Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute; Dr. Philip Larsen, Global Head of Research, Bayer AG; Rehan Verjee, President, EMD Serono; Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics
Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital; Daphne Zohar, Founder & CEO, PureTech Health; Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University; Dr. Stelios Papadopoulos, Chairman, Biogen
Moderator: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

Panelists: Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen; Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda; Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals; Dr. John Orloff, Head of Research & Development, Alexion; Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation
Moderator: Dr. Steve Uden, Co-Founder, Rallybio

Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals
Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson

Panelists: Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals; Arpa Garay, President, Global Pharmaceuticals, Commercial Analytics, Merck & Co.; Dr. Maya Said, Chief Executive Officer, Outcomes4Me; Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson; Nina Kjellson, General Partner, Canaan
Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals; Dr. David Reese, Executive Vice President, Research and Development, Amgen; Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline; Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
Moderator: Dr. Martin Mackay, Co-Founder, Rallybio